Purchases and Sales Made in Q1 2023 in Mi Nk Therapeutics, Inc. (INKT)
This table provides information about the institutional ownership of Mi Nk Therapeutics, Inc. (INKT) during Q1 2023. The information is specifically focused on institutions that hold shares of MiNK Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 12, 2023
Q1 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
10.3KNew |
$19.6K - $25.5K
|
10.3K
$7.52K
|
|
|
May 12, 2023
Q1 2023
|
Black Rock Inc.
New York, NY |
BUY
|
- |
354+ 3.37% |
$673 - $878
|
10.9K
$7.92K
|
|
|
May 12, 2023
Q1 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
1+ 3.13% |
$1.9 - $2.48
|
33
$24.1
|
|
|
May 15, 2023
Q1 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
May 15, 2023
Q1 2023
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-118- 51.98% |
$224 - $293
|
109
$79.6
|
|
|
May 12, 2023
Q1 2023
|
Ubs Group Ag
|
SELL
|
- |
-652- 26.04% |
$1.24K - $1.62K
|
1.85K
$1.35K
|
|
|
May 11, 2023
Q1 2023
|
First Republic Investment Management, Inc.
San Francisco, CA |
SELL
|
- |
-20.1K- 38.29% |
$38.2K - $49.8K
|
32.4K
$23.7K
|